Arpeggio Bio
YC S19Boulder, US · Founded 2018 · 20 employees · 3 known investors
Arpeggio Bio develops pharmaceutical drugs that target transcription factors using artificial intelligence and RNA-sequencing technology, with lead programs in development for melanoma treatment and rare disease applications.
Founders & leadership· Y Combinator alumni (S19)
Joey AzofeifainFounder
Investors · 3
In the news
- Arpeggio Bio Secures USD 3.2M in Seed Funding Roundfinsmes.com · 2020
- Arpeggio Bio Raises $3.2 Million in Seed Funding and CEO Named to the 2020 Forbes 30 Under 30 List in Healthcarebusinesswire.com · 2020